<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="ctx" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">ctx</book-part-id>
      <title-group>
        <title>Cerebrotendinous Xanthomatosis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Federico</surname>
            <given-names>Antonio</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Neuroscience <break/>University of Siena<break/>Siena, Italy</aff>
          <email>federico@unisi.it</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Dotti</surname>
            <given-names>Maria Teresa</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Neuroscience <break/>University of Siena<break/>Siena, Italy</aff>
          <email>dotti@unisi.it</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gallus</surname>
            <given-names>Gian Nicola</given-names>
          </name>
          <degrees>DSci</degrees>
          <aff>Neuroscience <break/>University of Siena<break/>Siena, Italy</aff>
          <email>gallus2@unisi.it</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2003-07-16" date-type="created">
          <day>16</day>
          <month>7</month>
          <year>2003</year>
        </date>
        <date iso-8601-date="2016-04-14" date-type="updated">
          <day>14</day>
          <month>4</month>
          <year>2016</year>
        </date>
        <date iso-8601-date="2011-10-20" date-type="revised">
          <day>20</day>
          <month>10</month>
          <year>2011</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="ccm" document-type="chapter">Cerebral Cavernous Malformation, Familial</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="char" document-type="chapter">Char Syndrome</related-object>
      <abstract id="ctx.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Cerebrotendinous xanthomatosis (CTX) is a lipid storage disease characterized by infantile-onset diarrhea, childhood-onset cataract, adolescent- to young adult-onset tendon xanthomas, and adult-onset progressive neurologic dysfunction (dementia, psychiatric disturbances, pyramidal and/or cerebellar signs, dystonia, atypical parkinsonism, peripheral neuropathy, and seizures). Chronic diarrhea from infancy may be the earliest clinical manifestation. In approximately 75% of affected individuals, cataracts are the first finding, often appearing in the first decade of life. Xanthomas appear in the second or third decade; they occur on the Achilles tendon, the extensor tendons of the elbow and hand, the patellar tendon, and the neck tendons. Xanthomas have been reported in the lung, bones, and central nervous system. Some individuals show cognitive impairment from early infancy, whereas the majority have normal or only slightly impaired intellectual function until puberty; dementia with slow deterioration in intellectual abilities occurs in the 20s in more than 50% of individuals. Neuropsychiatric symptoms such as behavioral changes, hallucinations, agitation, aggression, depression, and suicide attempts may be prominent. Pyramidal signs (i.e., spasticity) and/or cerebellar signs almost invariably become evident between ages 20 and 30 years.</p>
          <p>The biochemical abnormalities that distinguish CTX from other conditions with xanthomas include high plasma and tissue cholestanol concentration, normal-to-low plasma cholesterol concentration, decreased chenodeoxycholic acid, increased concentration of bile alcohols and their glyconjugates, and increased concentrations of cholestanol and apolipoprotein B in cerebrospinal fluid.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of CTX is established in a proband with the above clinical and biochemical findings and/or by the identification of biallelic pathogenic variants in <italic toggle="yes">CYP27A1</italic>.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Long-term treatment with chenodeoxycholic acid (CDCA) normalizes bile acid synthesis, normalizes plasma and CSF concentration of cholestanol, and improves neurophysiologic findings. Inhibitors of HMG-CoA reductase alone or in combination with CDCA are also effective in decreasing cholestanol concentration and improving clinical signs; however, they may induce muscle damage. Coenzyme Q<sub>10</sub> treatment may improve muscle weakness. Cataract extraction is typically required in at least one eye by age 50 years. Epilepsy, spasticity, and parkinsonism are treated symptomatically.</p>
          <p><italic toggle="yes">Prevention of primary manifestations:</italic> Early treatment with CDCA in presymptomatic individuals appears to prevent clinical manifestations.</p>
          <p><italic toggle="yes">Prevention of secondary complications</italic>: Calcium and vitamin D supplementation improve osteoporosis.</p>
          <p><italic toggle="yes">Surveillance:</italic> Annual neurologic and neuropsychological evaluation, cholestanol plasma concentration, brain MRI, echocardiogram, and assessment of total body density (TBD).</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Caution has been suggested with statins.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> Early diagnosis by biochemical testing or molecular genetic testing (if the two pathogenic variants in the family are known) allows for early treatment that may prevent or limit disease manifestations.</p>
          <p><italic toggle="yes">Pregnancy management:</italic> Treatment with chenodeoxycholic acid should not be interrupted during pregnancy.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>CTX is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk family members and prenatal testing for pregnancies at increased risk are possible if both <italic toggle="yes">CYP27A1</italic> pathogenic variants in the family are known.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="ctx.Diagnosis">
        <title>Diagnosis</title>
        <sec id="ctx.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Consensus clinical diagnostic criteria for cerebrotendinous xanthomatosis (CTX) have not been published. However, to aid in the diagnosis of CTX, <xref ref-type="bibr" rid="ctx.REF.mignarri.2014.421">Mignarri et al [2014]</xref> have developed a diagnostic flow chart based on an individual&#x02019;s degree-of-suspicion score as determined by clinical, family history, and radiographic findings. See <xref ref-type="bibr" rid="ctx.REF.mignarri.2014.421">Mignarri et al [2014]</xref> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://link.springer.com/article/10.1007/s10545-013-9674-3/fulltext.html#Tab2">Table 2. Suspicion index</ext-link> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://link.springer.com/article/10.1007/s10545-013-9674-3/fulltext.html#Fig1">Figure 1. Diagnostic flow chart</ext-link>).</p>
          <p>CTX, a lipid storage disease, <bold>should be suspected</bold> in individuals with the following clinical, radiographic, and laboratory findings:</p>
          <p>
            <bold>Clinical features</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Infantile-onset diarrhea</p>
            </list-item>
            <list-item>
              <p>Childhood-onset cataract</p>
            </list-item>
            <list-item>
              <p>Adolescent- to young adult-onset tendon xanthomas (<xref ref-type="fig" rid="ctx.F1">Figure 1</xref>)</p>
            </list-item>
            <list-item>
              <p>Adult-onset progressive neurologic dysfunction (dementia, psychiatric disturbances, pyramidal and/or cerebellar signs, and seizures)</p>
            </list-item>
          </list>
          <p>
            <bold>Brain imaging</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Bilateral hyperintensity of the dentate nuclei and cerebral and cerebellar white matter (<xref ref-type="fig" rid="ctx.F2">Figure 2</xref>) on brain MRI. Changes on brain CT and MRI include diffuse brain and cerebellar atrophy, white matter signal alterations, and bilateral focal cerebellar lesions [<xref ref-type="bibr" rid="ctx.REF.berginer.1981.1463">Berginer et al 1981</xref>, <xref ref-type="bibr" rid="ctx.REF.waterreus.1987.169">Waterreus et al 1987</xref>, <xref ref-type="bibr" rid="ctx.REF.berginer.1994.102">Berginer et al 1994</xref>, <xref ref-type="bibr" rid="ctx.REF.dotti.1994.1721">Dotti et al 1994</xref>, <xref ref-type="bibr" rid="ctx.REF.de_stefano.2001.121">De Stefano et al 2001</xref>, <xref ref-type="bibr" rid="ctx.REF.guerrera.2010.1189">Guerrera et al 2010</xref>, <xref ref-type="bibr" rid="ctx.REF.androdias.2012.364">Androdias et al 2012</xref>, <xref ref-type="bibr" rid="ctx.REF.mignarri.2012a.649">Mignarri et al 2012a</xref>].</p>
            </list-item>
            <list-item>
              <p>Increased brain lactate concentration (by MR spectroscopy). MR spectroscopy shows decreased n-acetylaspartate and increased lactate indicative of widespread brain mitochondrial dysfunction [<xref ref-type="bibr" rid="ctx.REF.de_stefano.2001.121">De Stefano et al 2001</xref>].</p>
            </list-item>
          </list>
          <p><bold>Laboratory findings.</bold> CTX is caused by deficiency of the mitochondrial enzyme sterol 27-hydroxylase with resulting cholestanol and cholesterol accumulation in virtually every tissue. Note: <xref ref-type="bibr" rid="ctx.REF.cali.1991.7779">Cali et al [1991]</xref> reported that the sterol 27-hydroxylase was often referred to in the literature as a sterol 26-hydroxylase; however, in accordance with IUPAC sterol nomenclature and the stereochemistry of the initial reaction catalyzed by this enzyme, the authors of this <italic toggle="yes">GeneReview</italic> will refer to it as sterol 27- hydroxylase. Laboratory findings include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>High</bold> plasma and tissue <bold>cholestanol</bold> concentration (<xref ref-type="table" rid="ctx.T.biochemical_abnormalities_in_cereb">Table 1</xref>).</p>
            </list-item>
            <list-item>
              <p>Normal to low plasma cholesterol concentration</p>
            </list-item>
            <list-item>
              <p>Markedly <bold>decreased</bold> formation of <bold>chenodeoxycholic acid</bold> resulting from impaired primary bile acid synthesis</p>
            </list-item>
            <list-item>
              <p><bold>Increased concentration of bile alcohols</bold> and their glyconjugates in bile, urine, and plasma (<xref ref-type="table" rid="ctx.T.biochemical_abnormalities_in_cereb">Table 1</xref>)</p>
            </list-item>
            <list-item>
              <p>Increased concentration of cholestanol and apolipoprotein B in cerebrospinal fluid (CSF) resulting from <bold>changes in the blood-brain barrier</bold></p>
            </list-item>
            <list-item>
              <p><bold>Increased</bold> plasma <bold>lactate</bold> concentration</p>
            </list-item>
          </list>
          <table-wrap id="ctx.T.biochemical_abnormalities_in_cereb" position="anchor" orientation="portrait">
            <label>Table 1. </label>
            <caption>
              <p>Biochemical Abnormalities in Cerebrotendinous Xanthomatosis (CTX)</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_ctx.T.biochemical_abnormalities_in_cereb_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_ctx.T.biochemical_abnormalities_in_cereb_1_1_1_1">Analyte</th>
                  <th id="hd_h_ctx.T.biochemical_abnormalities_in_cereb_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_ctx.T.biochemical_abnormalities_in_cereb_1_1_1_2">Source</th>
                  <th id="hd_h_ctx.T.biochemical_abnormalities_in_cereb_1_1_1_3" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Concentration<hr/></th>
                </tr>
                <tr>
                  <th headers="hd_h_ctx.T.biochemical_abnormalities_in_cereb_1_1_1_3" id="hd_h_ctx.T.biochemical_abnormalities_in_cereb_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">In CTX</th>
                  <th headers="hd_h_ctx.T.biochemical_abnormalities_in_cereb_1_1_1_3" id="hd_h_ctx.T.biochemical_abnormalities_in_cereb_1_1_2_2" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Normal</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_ctx.T.biochemical_abnormalities_in_cereb_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Cholestanol<hr/></td>
                  <td headers="hd_h_ctx.T.biochemical_abnormalities_in_cereb_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Plasma<hr/></td>
                  <td headers="hd_h_ctx.T.biochemical_abnormalities_in_cereb_1_1_1_3 hd_h_ctx.T.biochemical_abnormalities_in_cereb_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">&#x02264;5-10x normal<hr/></td>
                  <td headers="hd_h_ctx.T.biochemical_abnormalities_in_cereb_1_1_1_3 hd_h_ctx.T.biochemical_abnormalities_in_cereb_1_1_2_2" valign="middle" colspan="2" align="left" rowspan="1">330&#x000b1;30 &#x000b5;g/dL<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_ctx.T.biochemical_abnormalities_in_cereb_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">Bile alcohols</td>
                  <td headers="hd_h_ctx.T.biochemical_abnormalities_in_cereb_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Urine<hr/></td>
                  <td headers="hd_h_ctx.T.biochemical_abnormalities_in_cereb_1_1_1_3 hd_h_ctx.T.biochemical_abnormalities_in_cereb_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">14,000&#x000b1;3500 nmol/L<hr/></td>
                  <td headers="hd_h_ctx.T.biochemical_abnormalities_in_cereb_1_1_1_3 hd_h_ctx.T.biochemical_abnormalities_in_cereb_1_1_2_2" valign="middle" colspan="2" align="left" rowspan="1">Not detectable<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_ctx.T.biochemical_abnormalities_in_cereb_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Plasma</td>
                  <td headers="hd_h_ctx.T.biochemical_abnormalities_in_cereb_1_1_1_3 hd_h_ctx.T.biochemical_abnormalities_in_cereb_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">&#x02264;500-1000x normal values</td>
                  <td headers="hd_h_ctx.T.biochemical_abnormalities_in_cereb_1_1_1_3 hd_h_ctx.T.biochemical_abnormalities_in_cereb_1_1_2_2" valign="middle" colspan="2" align="left" rowspan="1">8.48&#x000b1;3.67</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
        </sec>
        <sec id="ctx.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of CTX <bold>is established</bold> in a proband with the clinical and biochemical testing findings above and/or by the identification of biallelic pathogenic variants in <italic toggle="yes">CYP27A1</italic> on molecular genetic testing (see <xref ref-type="table" rid="ctx.T.molecular_genetic_testing_used_in">Table 2</xref>).</p>
          <p>Molecular testing approaches can include <bold>single-gene testing</bold> or use of a <bold>multi-gene panel.</bold></p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing.</bold> Sequence analysis of <italic toggle="yes">CYP27A1</italic> is performed first followed by gene-targeted deletion/duplication analysis if only one or no pathogenic variant is found.</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">CYP27A1</italic> and other genes of interest (see <xref ref-type="sec" rid="ctx.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: The genes included and sensitivity of multi-gene panels vary by laboratory and over time.</p>
            </list-item>
          </list>
          <table-wrap id="ctx.T.molecular_genetic_testing_used_in" position="anchor" orientation="portrait">
            <label>Table 2. </label>
            <caption>
              <p>Molecular Genetic Testing Used in Cerebrotendinous Xanthomatosis</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_ctx.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_ctx.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_ctx.T.molecular_genetic_testing_used_in_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_ctx.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">CYP27A1</italic>
                    <hr/>
                  </td>
                  <td headers="hd_h_ctx.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup><hr/></td>
                  <td headers="hd_h_ctx.T.molecular_genetic_testing_used_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;90%<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_ctx.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>4</sup><hr/></td>
                  <td headers="hd_h_ctx.T.molecular_genetic_testing_used_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;8%&#x000a0;<sup>5</sup><hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_ctx.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Unknown&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_ctx.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                  <td headers="hd_h_ctx.T.molecular_genetic_testing_used_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="ctx.TF.2.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="ctx" object-id="ctx.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="ctx.TF.2.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="ctx.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="ctx.TF.2.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected (see <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="ctx-Table3.pdf" content-type="local-data">Table 3</inline-supplementary-material> [pdf]). For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="ctx.TF.2.4">
                <label>4. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="ctx.TF.2.5">
                <label>5. </label>
                <p>In 55 Italian cases [Author, personal observation]</p>
              </fn>
              <fn id="ctx.TF.2.6">
                <label>6. </label>
                <p><xref ref-type="bibr" rid="ctx.REF.hansson.2007.504">Hansson et al [2007]</xref> described an affected individual with two pathogenic variants in <italic toggle="yes">cis</italic> configuration on one allele of <italic toggle="yes">CYP27A1</italic>; the authors postulated that a second pathogenic variant in another, as-yet-unknown gene that is critical for the activity of sterol 27-hydroxylase may be cause of the phenotype.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="ctx.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="ctx.Clinical_Description">
          <title>Clinical Description</title>
          <p>Cerebrotendinous xanthomatosis (CTX) is a lipid storage disease characterized by infantile-onset diarrhea, childhood-onset cataract, adolescent- to young adult-onset tendon xanthomas, and adult-onset progressive neurologic dysfunction (dementia, psychiatric disturbances, pyramidal and/or cerebellar signs, dystonia, atypical parkinsonism, peripheral neuropathy, and seizures). The clinical features of 55 individuals with CTX were reported as follows: cataracts in 49 (89%), tendon xanthomas in 43 (78%), osteoporosis in 20/30 (67%), and diarrhea in 22 (40%). Neurologic involvement included intellectual disability in 33 (60%) and psychiatric disturbances in 24 (44%). Ataxia was observed in 20 (36%), paraparesis in 35 (64%), parkinsonism in five (9%) and peripheral neuropathy in 21/30 (70%). Seizures were observed in 18 (33%) (see <xref ref-type="fig" rid="ctx.F3">Figure 3</xref>). Intrafamilial variability is considerable [<xref ref-type="bibr" rid="ctx.REF.dotti.1996.12">Dotti et al 1996</xref>, <xref ref-type="bibr" rid="ctx.REF.nagai.1996.571">Nagai et al 1996</xref>, <xref ref-type="bibr" rid="ctx.REF.verrips.2000a.908">Verrips et al 2000a</xref>, <xref ref-type="bibr" rid="ctx.REF.federico.2003.633">Federico &#x00026; Dotti 2003</xref>, <xref ref-type="bibr" rid="ctx.REF.moghadasian.2004.42">Moghadasian 2004</xref>, <xref ref-type="bibr" rid="ctx.REF.mignarri.2014.421">Mignarri et al 2014</xref>].</p>
          <p>A distinction can be made between <xref ref-type="sec" rid="ctx.Systemic_Signs">systemic signs</xref> and <xref ref-type="sec" rid="ctx.Neurologic_Signs">neurologic signs</xref>, described in detail below.</p>
          <sec id="ctx.Systemic_Signs">
            <title>Systemic Signs</title>
            <p><bold>Enterohepatic system.</bold> Chronic diarrhea from infancy may be the earliest clinical manifestation of CTX [<xref ref-type="bibr" rid="ctx.REF.cruysberg.1991.606">Cruysberg et al 1991</xref>, <xref ref-type="bibr" rid="ctx.REF.cruysberg.2002.1975">Cruysberg 2002</xref>]. Gallstones have been reported on occasion.</p>
            <p><bold>Eye.</bold> In approximately 75% of affected individuals, cataracts are the first finding, often appearing in the first decade of life. In 25% of individuals, cataracts are first observed after age 40 years. Cataracts may be visually significant opacities requiring lensectomy or visually insignificant cortical opacities. The appearance can include irregular cortical opacities, anterior polar cataracts, and dense posterior subcapsular cataracts [<xref ref-type="bibr" rid="ctx.REF.cruysberg.1995.597">Cruysberg et al 1995</xref>].</p>
            <p>Other findings include palpebral xanthelasmas [<xref ref-type="bibr" rid="ctx.REF.van_bogaert.1937">Van Bogaert et al 1937</xref>, <xref ref-type="bibr" rid="ctx.REF.philippart.1969.603">Philippart &#x00026; Van Bogaert 1969</xref>], optic nerve atrophy [<xref ref-type="bibr" rid="ctx.REF.schimschock.1968.688">Schimschock et al 1968</xref>], and proptosis [<xref ref-type="bibr" rid="ctx.REF.morgan.1989.1011">Morgan et al 1989</xref>]. In 13 individuals reported by <xref ref-type="bibr" rid="ctx.REF.dotti.2001.696">Dotti et al [2001]</xref> ranging in age from 32 to 54 years, all had cataracts, approximately 50% had optic disk paleness, 30% had signs of premature retinal senescence with retinal vessel sclerosis, 15% had cholesterol-like deposits along vascular arcades, and 15% had myelinated nerve fibers.</p>
            <p><xref ref-type="bibr" rid="ctx.REF.khan.2013.956">Khan et al [2013]</xref> reported the unique finding of fleck lenticular opacities in three children with CTX; these affected children also had capsular opacities (posterior only or posterior and anterior) that caused visual symptoms.</p>
            <p><bold>Xanthomas</bold> appear in the second or third decade. In addition to the classic xanthomas of the Achilles tendon, xanthomas also occur on the extensor tendons of the elbow and hand, the patellar tendon (<xref ref-type="fig" rid="ctx.F1">Figure 1</xref>), and the neck tendons. Xanthomas have been reported in the lung, bones, and central nervous system (CNS) [<xref ref-type="bibr" rid="ctx.REF.brienza.2015.981">Brienza et al 2015</xref>].</p>
            <p><bold>Cardiovascular system.</bold> Premature atherosclerosis and coronary artery disease have been reported [<xref ref-type="bibr" rid="ctx.REF.schimschock.1968.688">Schimschock et al 1968</xref>, <xref ref-type="bibr" rid="ctx.REF.fujiyama.1991.1">Fujiyama et al 1991</xref>, <xref ref-type="bibr" rid="ctx.REF.kerleau.1993.1460">Kerleau et al 1993</xref>, <xref ref-type="bibr" rid="ctx.REF.valdivielso.2004.680">Valdivielso et al 2004</xref>, <xref ref-type="bibr" rid="ctx.REF.frihayed.2005.992">Frih-Ayed et al 2005</xref>], as has lipomatous hypertrophy of the atrial septum [<xref ref-type="bibr" rid="ctx.REF.dotti.1998.723">Dotti et al 1998</xref>]. The increased prevalence of atherosclerosis in individuals with CTX can be partially explained by the following mechanisms: alteration of the plasma lipid and lipoprotein profile; alteration of bile alcohols; lack of sterol 27-hydroxylase activity in the cellular constituents of the atheroma; and absence of a defense mechanism for macrophages in the metabolism of cholesterol into 27-hydroxycholesterol and 3p-hydroxy5-cholestanoic acid [<xref ref-type="bibr" rid="ctx.REF.leitersdorf.1994.907">Leitersdorf et al 1994</xref>].</p>
            <p><bold>Skeleton.</bold> Bone involvement is characterized by granulomatous lesions in the lumbar vertebrae and femur, osteopenia and increased risk of bone fractures, and impaired adsorption of radiocalcium, which improves with chenodeoxycholic acid treatment [<xref ref-type="bibr" rid="ctx.REF.berginer.1993.69">Berginer et al 1993</xref>, <xref ref-type="bibr" rid="ctx.REF.federico.1993.67">Federico et al 1993</xref>, <xref ref-type="bibr" rid="ctx.REF.martini.2013.282">Martini et al 2013</xref>]. Osteopenia is evident by total body densitometry in untreated individuals. Individuals may have marked thoracic kyphosis.</p>
            <p><bold>Endocrine abnormalities.</bold> Hypothyroidism has occasionally been reported [<xref ref-type="bibr" rid="ctx.REF.philippart.1969.603">Philippart &#x00026; Van Bogaert 1969</xref>, <xref ref-type="bibr" rid="ctx.REF.bouwes_bavinck.1986.1269">Bouwes Bavinck et al 1986</xref>, <xref ref-type="bibr" rid="ctx.REF.idouji.1991.402">Idouji et al 1991</xref>].</p>
            <p><bold>Premature aging.</bold> Early-onset cataract, osteopenia with bone fractures and loss of teeth, atherosclerosis, and neurologic impairment with dementia and/or parkinsonism, associated with the characteristic facies, suggest a generalized premature aging process [<xref ref-type="bibr" rid="ctx.REF.dotti.1991.371">Dotti et al 1991</xref>].</p>
          </sec>
          <sec id="ctx.Neurologic_Signs">
            <title>Neurologic Signs</title>
            <p><bold>Intellectual disability or dementia</bold> following slow deterioration in intellectual abilities occurs in the 20s in more than 50% of individuals [<xref ref-type="bibr" rid="ctx.REF.verrips.2000b.407">Verrips et al 2000b</xref>]. Some individuals show cognitive impairment from early infancy, whereas the majority have normal or only slightly impaired intellectual function until puberty. In the spinal form, mainly characterized by myelopathy and spastic paraparesis, intellect is almost always normal.</p>
            <p><bold>Neuropsychiatric symptoms</bold> including behavioral changes, hallucinations, agitation, aggression, depression, and suicide attempts may be prominent.</p>
            <p><bold>Pyramidal signs (i.e., spasticity) and/or cerebellar signs</bold> are almost invariably present between ages 20 and 30 years. A spinal form, in which spastic paraparesis is the main clinical symptom, was described by <xref ref-type="bibr" rid="ctx.REF.van_bogaert.1962.433">Van Bogaert [1962]</xref> and more recently by <xref ref-type="bibr" rid="ctx.REF.verrips.1999a.1589">Verrips et al [1999a]</xref> and <xref ref-type="bibr" rid="ctx.REF.mignarri.2011.783">Mignarri et al [2011]</xref>.</p>
            <p><bold>Extrapyramidal manifestations</bold> including dystonia and atypical parkinsonism have been reported on occasion [<xref ref-type="bibr" rid="ctx.REF.fiorelli.1990.76">Fiorelli et al 1990</xref>, <xref ref-type="bibr" rid="ctx.REF.rogelet.1992.541">Rogelet et al 1992</xref>, <xref ref-type="bibr" rid="ctx.REF.dotti.2000.1017">Dotti et al 2000</xref>, <xref ref-type="bibr" rid="ctx.REF.grandas.2002.1396">Grandas et al 2002</xref>, <xref ref-type="bibr" rid="ctx.REF.mignarri.2012b.99">Mignarri et al 2012b</xref>]. Although palatal myoclonus was observed in the first individual reported [<xref ref-type="bibr" rid="ctx.REF.van_bogaert.1937">Van Bogaert et al 1937</xref>], it was not observed in a large series of affected individuals [<xref ref-type="bibr" rid="ctx.REF.dotti.2001.696">Dotti et al 2001</xref>].</p>
            <p><bold>Seizures</bold> are reported in approximately 50% of individuals with CTX [<xref ref-type="bibr" rid="ctx.REF.matsumuro.1990.207">Matsumuro et al 1990</xref>, <xref ref-type="bibr" rid="ctx.REF.arlazoroff.1991.657">Arlazoroff et al 1991</xref>, <xref ref-type="bibr" rid="ctx.REF.dotti.1996.12">Dotti et al 1996</xref>].</p>
            <p><bold>Peripheral neuropathy</bold> is evident on electrophysiologic studies [<xref ref-type="bibr" rid="ctx.REF.ohnishi.1979.43">Ohnishi et al 1979</xref>, <xref ref-type="bibr" rid="ctx.REF.argov.1986.89">Argov et al 1986</xref>, <xref ref-type="bibr" rid="ctx.REF.federico.1987.360">Federico et al 1987</xref>, <xref ref-type="bibr" rid="ctx.REF.ben_hamida.1991.385">Ben Hamida et al 1991</xref>, <xref ref-type="bibr" rid="ctx.REF.ginanneschi.2013.268">Ginanneschi et al 2013</xref>], which reveal decreased nerve conduction velocities (NCV) and abnormalities in somatosensory, motor, brain stem, and visual evoked potentials. Clinical manifestations related to peripheral nerve involvement are distal muscle atrophy and pes cavus. Sensory abnormalities are rarely described.</p>
          </sec>
          <sec id="ctx.Neuroimaging">
            <title>Neuroimaging</title>
            <p>The quantitative assessment of brain damage in CTX with use of magnetization transfer MRI has also been described [<xref ref-type="bibr" rid="ctx.REF.inglese.2003.495">Inglese et al 2003</xref>].</p>
          </sec>
          <sec id="ctx.Pathology_Findings">
            <title>Pathology Findings</title>
            <p><bold>Histologic changes.</bold> Histologic liver findings include electron-dense amorphous material surrounded by smooth endoplasmic reticulum [<xref ref-type="bibr" rid="ctx.REF.salen.1978.82">Salen et al 1978</xref>] and abnormalities in mitochondria with paracrystalline inclusions and increased number of peroxisomes [<xref ref-type="bibr" rid="ctx.REF.federico.1989">Federico 1989</xref>]. Xanthomas are characterized by birefringent crystalline material surrounded by numerous multinucleate giant cells with foamy cytoplasm.</p>
            <p><bold>Neuropathology.</bold> Classic CNS pathology findings in CTX include granulomatous and xanthomatous lesions in the cerebellar hemispheres, globus pallidus, and cerebellar peduncles. Demyelination and gliosis and involvement of the long tract of the spinal cord have been described [<xref ref-type="bibr" rid="ctx.REF.van_bogaert.1937">Van Bogaert et al 1937</xref>, <xref ref-type="bibr" rid="ctx.REF.van_bogaert.1962.433">Van Bogaert 1962</xref>]. Nerve biopsy reveals primary axonal degeneration, demyelination, and remyelination. <xref ref-type="bibr" rid="ctx.REF.federico.1991.734">Federico et al [1991]</xref> found mild myopathic changes of increased variability of fiber size with randomly distributed atrophic fibers. Ultrastructural abnormalities included mitochondrial subsarcolemmal aggregates and morphologic changes of these organelles [<xref ref-type="bibr" rid="ctx.REF.federico.1991.734">Federico et al 1991</xref>]. Reduced respiratory chain enzyme activity has been observed [<xref ref-type="bibr" rid="ctx.REF.dotti.1995.106">Dotti et al 1995</xref>].</p>
          </sec>
          <sec id="ctx.Heterozygotes">
            <title>Heterozygotes</title>
            <p>Heterozygotes are generally asymptomatic; however, clinical findings have been reported in heterozygotes ranging from an increased incidence of cardiovascular disorders and gall stones to a symptomatic heterozygote with biochemically proven CTX [<xref ref-type="bibr" rid="ctx.REF.sugama.2001.379">Sugama et al 2001</xref>; Author, personal observation]. <xref ref-type="bibr" rid="ctx.REF.hansson.2007.504">Hansson et al [2007]</xref> described an individual with CTX with a heterozygous <italic toggle="yes">CYP27A1</italic> pathogenic variant and a presumed second pathogenic variant in an undefined gene that possibly encodes a protein responsible for transport of cholesterol into the mitochondria.</p>
          </sec>
        </sec>
        <sec id="ctx.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>No genotype-phenotype correlations have been identified [<xref ref-type="bibr" rid="ctx.REF.dotti.1996.12">Dotti et al 1996</xref>, <xref ref-type="bibr" rid="ctx.REF.verrips.2000c.520">Verrips et al 2000c</xref>]. The interaction of many genes and other factors may influence the clinical presentation.</p>
        </sec>
        <sec id="ctx.Nomenclature">
          <title>Nomenclature</title>
          <p>Terms used in the past for cerebrotendinous xanthomatosis and no longer in use include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Cerebral cholesterinosis</p>
            </list-item>
            <list-item>
              <p>Cerebrotendinous cholesterosis</p>
            </list-item>
            <list-item>
              <p>Van Bogaert-Scherer-Epstein syndrome</p>
            </list-item>
          </list>
        </sec>
        <sec id="ctx.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence of CTX is estimated at 0.13:100,000 individuals (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.orpha.net/orphacom/cahiers/docs/GB/Prevalence_of_rare_diseases_by_alphabetical_list.pdf">Orphanet: Prevalence and incidence of rare diseases: Bibilographic data</ext-link> [pdf]).</p>
          <p>The prevalence of CTX caused by biallelic (homozygous) p.Arg395Cys pathogenic variants has been estimated at 1:50,000 among persons of northern European heritage [<xref ref-type="bibr" rid="ctx.REF.lorincz.2005.1459">Lorincz et al 2005</xref>].</p>
          <p>Series of affected individuals have been reported in Israel and the US [<xref ref-type="bibr" rid="ctx.REF.berginer.1984.1649">Berginer et al 1984</xref>], Italy [<xref ref-type="bibr" rid="ctx.REF.de_stefano.2001.121">De Stefano et al 2001</xref>, <xref ref-type="bibr" rid="ctx.REF.dotti.2001.696">Dotti et al 2001</xref>], Spain [<xref ref-type="bibr" rid="ctx.REF.pilodelafuente.2011.1203">Pilo-de-la-Fuente et al 2011</xref>], Japan [<xref ref-type="bibr" rid="ctx.REF.kuriyama.1991.225">Kuriyama et al 1991</xref>], and the Netherlands [<xref ref-type="bibr" rid="ctx.REF.waterreus.1987.169">Waterreus et al 1987</xref>, <xref ref-type="bibr" rid="ctx.REF.verrips.2000a.908">Verrips et al 2000a</xref>]. Affected individuals have been reported in Belgium [<xref ref-type="bibr" rid="ctx.REF.van_bogaert.1937">Van Bogaert et al 1937</xref>, <xref ref-type="bibr" rid="ctx.REF.philippart.1969.603">Philippart &#x00026; Van Bogaert 1969</xref>], Brazil [<xref ref-type="bibr" rid="ctx.REF.canelas.1983.305">Canelas et al 1983</xref>], Canada [<xref ref-type="bibr" rid="ctx.REF.pastershank.1974.282">Pastershank et al 1974</xref>], France [<xref ref-type="bibr" rid="ctx.REF.rogelet.1992.541">Rogelet et al 1992</xref>], Iran [<xref ref-type="bibr" rid="ctx.REF.farpour.1975.223">Farpour &#x00026; Mahloudji 1975</xref>], Norway [<xref ref-type="bibr" rid="ctx.REF.schreiner.1975.405">Schreiner et al 1975</xref>], Tunisia [<xref ref-type="bibr" rid="ctx.REF.ben_hamida.1991.385">Ben Hamida et al 1991</xref>], Spain [<xref ref-type="bibr" rid="ctx.REF.campdelacreu.2002.647">Campdelacreu et al 2002</xref>], China [<xref ref-type="bibr" rid="ctx.REF.ko.2001.30">Ko &#x00026; Lee 2001</xref>], and Sweden [<xref ref-type="bibr" rid="ctx.REF.rystedt.2002.259">Rystedt et al 2002</xref>].</p>
        </sec>
      </sec>
      <sec id="ctx.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with pathogenic variants in <italic toggle="yes">CYP27A1</italic>.</p>
      </sec>
      <sec id="ctx.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold>Xanthomas.</bold> Differential diagnosis includes the following:</p>
        <list list-type="bullet">
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="stsl" document-type="chapter">Sitosterolemia</related-object>, inherited sterol storage disease characterized by tendon or tuberous xanthomas, a strong predisposition to premature atherosclerosis, and abnormal hematologic findings. Serum concentration of plant sterols (sitosterol and campesterol) is increased. Primary neurologic signs and cataracts are not present. Spastic paraparesis may occur as a result of spinal cord compression by multiple intradural, extramedullary xanthomas [<xref ref-type="bibr" rid="ctx.REF.hatanaka.1990.390">Hatanaka et al 1990</xref>]. Sitosterolemia is inherited in an autosomal recessive manner and caused by biallelic pathogenic variants in either <italic toggle="yes">ABCG5</italic> or <italic toggle="yes">ABCG8</italic>.</p>
          </list-item>
          <list-item>
            <p>Hypercholesterolemia and hyperlipemia (especially type IIa), in which plasma cholestanol level is normal. See <related-object link-type="booklink" source-id="gene" document-id="hyperchol" document-type="chapter">Familial Hypercholesterolemia</related-object>.</p>
          </list-item>
        </list>
        <p>When xanthomas are not evident, the differential diagnosis of cerebrotendinous xanthomatosis (CTX), includes all forms of progressive mental deterioration [<xref ref-type="bibr" rid="ctx.REF.gilad.1999.405">Gilad et al 1999</xref>, <xref ref-type="bibr" rid="ctx.REF.verrips.2000b.407">Verrips et al 2000b</xref>].</p>
        <p><bold>Early-onset cataract.</bold>
<xref ref-type="bibr" rid="ctx.REF.cruysberg.2002.1975">Cruysberg [2002]</xref> reported that individuals with CTX comprise the second-largest group with early-onset cataract and known neurologic disease. (<related-object link-type="booklink" source-id="gene" document-id="myotonic-d" document-type="chapter">Myotonic dystrophy type 1</related-object> is the largest group.) Unexplained juvenile-onset cataracts associated with infantile-onset chronic diarrhea and intellectual disability or deterioration strongly suggest the possibility of CTX [<xref ref-type="bibr" rid="ctx.REF.cruysberg.1991.606">Cruysberg et al 1991</xref>, <xref ref-type="bibr" rid="ctx.REF.cruysberg.1995.597">Cruysberg et al 1995</xref>, <xref ref-type="bibr" rid="ctx.REF.verrips.2000b.407">Verrips et al 2000b</xref>].</p>
      </sec>
      <sec id="ctx.Management">
        <title>Management</title>
        <sec id="ctx.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with cerebrotendinous xanthomatosis, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>EMG and nerve conduction velocity in order to evaluate for peripheral neuropathy</p>
            </list-item>
            <list-item>
              <p>Cardiologic evaluation including EKG and echocardiogram</p>
            </list-item>
            <list-item>
              <p>Laboratory investigations of lipids including measurement of plasma cholestanol level (if not performed as part of the diagnostic evaluation)</p>
            </list-item>
            <list-item>
              <p>Evaluation for osteoporosis</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="ctx.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p><bold>Chenodeoxycholic acid (CDCA).</bold> Long-term treatment with CDCA (750 mg/day in adults) normalizes bile acid synthesis (leading to disappearance of abnormal metabolites from serum, bile, and urine), normalizes plasma and CSF concentration of cholestanol by suppressing cholestanol biosynthesis, and improves neurophysiologic findings [<xref ref-type="bibr" rid="ctx.REF.mondelli.1992.469">Mondelli et al 1992</xref>, <xref ref-type="bibr" rid="ctx.REF.mondelli.2001.29">Mondelli et al 2001</xref>] and other clinical manifestations including osteoporosis [<xref ref-type="bibr" rid="ctx.REF.federico.1993.67">Federico et al 1993</xref>]. For recent reports see: <xref ref-type="bibr" rid="ctx.REF.bonnot.2010.231">Bonnot et al [2010]</xref>, <xref ref-type="bibr" rid="ctx.REF.ginanneschi.2013.268">Ginanneschi et al [2013]</xref>, <xref ref-type="bibr" rid="ctx.REF.martini.2013.282">Martini et al [2013]</xref>, and <xref ref-type="bibr" rid="ctx.REF.yahalom.2013.78">Yahalom et al [2013]</xref>.</p>
          <p>Treatment with CDCA has been reported to lead to the following [<xref ref-type="bibr" rid="ctx.REF.mondelli.2001.29">Mondelli et al 2001</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>Normalization of nerve conduction velocities and subsequent stabilization</p>
            </list-item>
            <list-item>
              <p>Slow and continuous improvement in motor evoked potentials (MEPs) and sensory evoked potentials (SEPs)</p>
            </list-item>
            <list-item>
              <p>Overall stabilization of clinical manifestations without significant improvement of neurologic deficits.</p>
              <list list-type="bullet">
                <list-item>
                  <p>In peripheral nerves CDCA treatment did not influence the number of axons activated by maximum electrical stimulation but instead it increased the conduction of the still-excitable fibers. This suggests that CDCA treatment promotes myelin synthesis in nerve fibers with residual unaffected axons.</p>
                </list-item>
                <list-item>
                  <p>The effect of therapy may therefore depend largely on the extent of irreversible structural damage to axons.</p>
                </list-item>
                <list-item>
                  <p>CDCA treatment may be more useful when started early. In a case in which treatment onset was at birth the development of disease appears to be delayed [Authors, personal data; <xref ref-type="bibr" rid="ctx.REF.luyckx.2014.9">Luyckx et al 2014</xref>].</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p><bold>Inhibitors of HMG-CoA reductase</bold> alone or in combination with CDCA are also effective in decreasing cholestanol concentration and improving clinical signs [<xref ref-type="bibr" rid="ctx.REF.peynet.1991.434">Peynet et al 1991</xref>, <xref ref-type="bibr" rid="ctx.REF.verrips.1999b.233">Verrips et al 1999b</xref>]. However, because of clinical evidence that HMG-CoA reductase inhibitors may induce muscle damage and even rhabdomyolysis, caution is required in the use of these drugs [<xref ref-type="bibr" rid="ctx.REF.federico.1994.2218">Federico &#x00026; Dotti 1994</xref>].</p>
          <p><bold>Low-density lipoprotein (LDL) apheresis</bold> has been proposed as a possible treatment; results are controversial [<xref ref-type="bibr" rid="ctx.REF.mimura.1993.227">Mimura et al 1993</xref>, <xref ref-type="bibr" rid="ctx.REF.berginer.1994.229">Berginer &#x00026; Salen 1994</xref>, <xref ref-type="bibr" rid="ctx.REF.dotti.2004.185">Dotti et al 2004</xref>].</p>
          <p><bold>Coenzyme Q<sub>10</sub></bold> (CoQ<sub>10</sub>) treatment may improve muscle weakness.</p>
          <p><bold>Liver transplantation</bold>, although never performed in individuals with CTX, remains a possibility.</p>
          <p><bold>Eyes.</bold> Cataract extraction is typically required in at least one eye by age 50 years.</p>
          <p><bold>Symptomatic treatments</bold> for epilepsy, spasticity, and parkinsonism have been utilized. Parkinsonism is poorly responsive to levodopa, whereas an antihistamine drug, diphenylpyraline hydrochloride, had an excellent effect in three individuals [<xref ref-type="bibr" rid="ctx.REF.ohno.2001.95">Ohno et al 2001</xref>].</p>
        </sec>
        <sec id="ctx.Prevention_of_Primary_Manifestations">
          <title>Prevention of Primary Manifestations</title>
          <p>Early treatment with CDCA in presymptomatic individuals appears to prevent clinical manifestations (see <xref ref-type="sec" rid="ctx.Treatment_of_Manifestations">Treatment of Manifestations</xref>).</p>
        </sec>
        <sec id="ctx.Prevention_of_Secondary_Complication">
          <title>Prevention of Secondary Complications</title>
          <p>Calcium and vitamin D supplementation improve osteoporosis.</p>
        </sec>
        <sec id="ctx.Surveillance">
          <title>Surveillance</title>
          <p>Recommended annual surveillance includes the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Neurologic and neuropsychologic evaluation</p>
            </list-item>
            <list-item>
              <p>Cholestanol plasma concentration</p>
            </list-item>
            <list-item>
              <p>Brain MRI</p>
            </list-item>
            <list-item>
              <p>Echocardiography</p>
            </list-item>
            <list-item>
              <p>Measurement of total body density (TBD)</p>
            </list-item>
          </list>
        </sec>
        <sec id="ctx.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Caution in the use of statins has been suggested [<xref ref-type="bibr" rid="ctx.REF.federico.2001.1743">Federico &#x00026; Dotti 2001</xref>].</p>
        </sec>
        <sec id="ctx.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to clarify the genetic status of apparently asymptomatic older and younger sibs of an affected individual by molecular genetic testing of the <italic toggle="yes">CYP27A1</italic> pathogenic variants in the family in order to identify as early as possible those who would benefit from prompt initiation of treatment. If the pathogenic variants in the family are not known, biochemical testing of at-risk individuals can be pursued.</p>
          <p>See <xref ref-type="sec" rid="ctx.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="ctx.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>Treatment with chenodeoxycholic acid should not be interrupted during pregnancy.</p>
        </sec>
        <sec id="ctx.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Therapies with statins and LDL apheresis have been reported [<xref ref-type="bibr" rid="ctx.REF.dotti.2004.185">Dotti et al 2004</xref>]. Cholic acid was used to treat two affected siblings from infancy with resulting improvement in symptoms [<xref ref-type="bibr" rid="ctx.REF.pierre.2008.s241">Pierre et al 2008</xref>].</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
        <sec id="ctx.Other">
          <title>Other</title>
          <p>Therapies with ursodeoxicolic acid, lovastatin, and cholestyramine have been reported to be ineffective [<xref ref-type="bibr" rid="ctx.REF.tint.1989.633">Tint et al 1989</xref>, <xref ref-type="bibr" rid="ctx.REF.batta.2004.556">Batta et al 2004</xref>].</p>
        </sec>
      </sec>
      <sec id="ctx.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="ctx.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Cerebrotendinous xanthomatosis (CTX) is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="ctx.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">CYP27A1</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are generally asymptomatic, although clinical findings have been reported in a few heterozygotes. (See <xref ref-type="sec" rid="ctx.Heterozygotes">Heterozygotes</xref>.)</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are generally asymptomatic. (See <xref ref-type="sec" rid="ctx.Heterozygotes">Heterozygotes</xref>.)</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with CTX are obligate heterozygotes (carriers) for a <italic toggle="yes">CYP27A1</italic> pathogenic variant.</p>
          <p><bold>Other family members.</bold> Each sib of the proband's parents is at a 50% risk of being a carrier of a <italic toggle="yes">CYP27A1</italic> pathogenic variant.</p>
        </sec>
        <sec id="ctx.Carrier_Heterozygote_Detection">
          <title>Carrier (Heterozygote) Detection</title>
          <p>Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">CYP27A1</italic> pathogenic variants in the family.</p>
        </sec>
        <sec id="ctx.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="ctx.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="ctx.Prenatal_Testing_and_Preimplantation">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">CYP27A1</italic> pathogenic variants have been identified in an affected family member, prenatal testing and preimplantation genetic diagnosis for a pregnancy at increased risk are possible options.</p>
        </sec>
      </sec>
      <sec id="ctx.Resources">
        <title>Resources</title>
      </sec>
      <sec id="ctx.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">CYP27A1</italic> has nine exons [<xref ref-type="bibr" rid="ctx.REF.leitersdorf.1993.2488">Leitersdorf et al 1993</xref>]. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="ctx" object-id="ctx.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic allelic variants.</bold>
<italic toggle="yes">CYP27A1</italic> pathogenic variants have been reported by <xref ref-type="bibr" rid="ctx.REF.cali.1991.7779">Cali et al [1991]</xref>, <xref ref-type="bibr" rid="ctx.REF.verrips.2000a.908">Verrips et al [2000a]</xref>, and <xref ref-type="bibr" rid="ctx.REF.gallus.2006.143">Gallus et al [2006]</xref>.</p>
        <p>See <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="ctx-Table3.pdf" content-type="local-data">Table 3</inline-supplementary-material> (pdf).</p>
        <p><bold>Normal gene product.</bold> The sterol 27-hydroxylase enzyme consists of 531 amino acids. Residues 1-33 encode the transit peptide that directs the protein to the mitochondrion. The mature mitocondrial peptide has 498 amino acids and contains putative binding sites for adrenodoxin and heme encoded by the region between exons 6 and 8.</p>
        <p><bold>Abnormal gene product.</bold> Inactive truncated sterol 27-hydroxylase protein leads to several metabolic derangements including increased cholestanol production and bile alcohols [<xref ref-type="bibr" rid="ctx.REF.bjorkhem.1995">Bjorkhem &#x00026; Boberg 1995</xref>]. Many of the reported pathogenic variants involve splice sites and are predicted to affect mRNA stability or lead to the formation of abnormal mRNA with translation products that are devoid of an adrenodoxin-binding region (residues 351-356) and/or the heme-binding site (residue 453-464), important for enzyme activity. Pathogenic nonsense variants are predicted to result in truncated peptides devoid of function. Approximately 50% of pathogenic variants are missense variants that are predicted to lead to the expression of an abnormal sterol 27-hydroxylase.</p>
      </sec>
      <sec id="ctx.References">
        <title>References</title>
        <sec id="ctx.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="ctx.Literature_Cited.reflist0">
            <ref id="ctx.REF.androdias.2012.364">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Androdias</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vukusic</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gignoux</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Acquaviva</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zabot</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Couvert</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrie</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Confavreux</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Labauge</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Leukodystrophy with a cerebellar cystic aspect and intracranial atherosclerosis: an atypical presentation of cerebrotendinous xanthomatosis.</article-title>
                <source>J Neurol</source>
                <volume>259</volume>
                <fpage>364</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">21769531</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.argov.1986.89">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Argov</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soffer</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eisenberg</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimmerman</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>1986</year>
                <article-title>Chronic demyelinating peripheral neuropathy in cerebrotendinous xanthomatosis.</article-title>
                <source>Ann Neurol.</source>
                <volume>20</volume>
                <fpage>89</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">3017187</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.arlazoroff.1991.657">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Arlazoroff</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roitberg</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Werber</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shidlo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berginer</surname>
                    <given-names>VM</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Epileptic seizure as a presenting symptom of cerebrotendinous xanthomatosis.</article-title>
                <source>Epilepsia.</source>
                <volume>32</volume>
                <fpage>657</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">1915172</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.batta.2004.556">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Batta</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salen</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tint</surname>
                    <given-names>GS</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Hydrophilic 7 beta-hydroxy bile acids, lovastatin, and cholestyramine are ineffective in the treatment of cerebrotendinous xanthomatosis.</article-title>
                <source>Metabolism</source>
                <volume>53</volume>
                <fpage>556</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">15131757</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.ben_hamida.1991.385">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ben Hamida</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chabbi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben Hamida</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mhiri</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kallel</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Peripheral neuropathy in a sporadic case of cerebrotendinous xanthomatosis.</article-title>
                <source>Rev Neurol (Paris)</source>
                <volume>147</volume>
                <fpage>385</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">1649488</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.berginer.1994.102">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Berginer</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berginer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korczyn</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tadmor</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>Magnetic resonance imaging in cerebrotendinous xanthomatosis: a prospective clinical and neuroradiological study.</article-title>
                <source>J Neurol Sci</source>
                <volume>122</volume>
                <fpage>102</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">8195796</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.berginer.1981.1463">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Berginer</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berginer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salen</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shefer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimmerman</surname>
                    <given-names>RD</given-names>
                  </name>
                </person-group>
                <year>1981</year>
                <article-title>Computed tomography in cerebrotendinous xanthomatosis.</article-title>
                <source>Neurology</source>
                <volume>31</volume>
                <fpage>1463</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">7198194</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.berginer.1994.229">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Berginer</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salen</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>LDL-apheresis cannot be recommended for treatment of cerebrotendinous xanthomatosis.</article-title>
                <source>J Neurol Sci</source>
                <volume>121</volume>
                <fpage>229</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">8158220</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.berginer.1984.1649">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Berginer</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salen</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shefer</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1984</year>
                <article-title>Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.</article-title>
                <source>N Engl J Med</source>
                <volume>311</volume>
                <fpage>1649</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">6504105</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.berginer.1993.69">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Berginer</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shany</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alkalay</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berginer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dekel</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salen</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tint</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gazit</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Osteoporosis and increased bone fractures in cerebrotendinous xanthomatosis.</article-title>
                <source>Metabolism</source>
                <volume>42</volume>
                <fpage>69</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">8446051</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.bjorkhem.1995">
              <mixed-citation publication-type="book">Bjorkhem I, Boberg KM. Inborn errors in bile and biosynthesis and storage of sterols other than cholesterol. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. <italic toggle="yes">The Metabolic and Molecular Basis of Inherited Disease.</italic> 7 ed. New York, NY: McGraw-Hill; 1995:2073-99.</mixed-citation>
            </ref>
            <ref id="ctx.REF.bonnot.2010.231">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bonnot</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fraidakis</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucanto</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chauvin</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelley</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plaza</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dubourg</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyon-Caen</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sedel</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Cerebrotendinous xanthomatosis presenting with severe externalized disorder: improvement after one year of treatment with chenodeoxycholic Acid.</article-title>
                <source>CNS Spectr</source>
                <volume>15</volume>
                <fpage>231</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">20414172</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.bouwes_bavinck.1986.1269">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bouwes Bavinck</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermeer</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gevers Leuven</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koopman</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolthers</surname>
                    <given-names>BG</given-names>
                  </name>
                </person-group>
                <year>1986</year>
                <article-title>Capillary gas chromatography of urine samples in diagnosing cerebrotendinous xanthomatosis.</article-title>
                <source>Arch Dermatol</source>
                <volume>122</volume>
                <fpage>1269</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">3777973</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.brienza.2015.981">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brienza</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fiermonte</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cambieri</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mignarri</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fiorelli</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Enlarging brain xanthomas in a patient with cerebrotendinous xanthomatosis.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>38</volume>
                <fpage>981</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">25567502</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.cali.1991.7779">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cali</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hsieh</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Francke</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russell</surname>
                    <given-names>DW</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis.</article-title>
                <source>J Biol Chem</source>
                <volume>266</volume>
                <fpage>7779</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">2019602</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.campdelacreu.2002.647">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Campdelacreu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munoz</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cervera</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jauma</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giros</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolosa</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Cerebrotendinous xanthomatosis without tendinous xanthomas: presentation of two cases.</article-title>
                <source>Neurologia</source>
                <volume>17</volume>
                <fpage>647</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">12487962</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.canelas.1983.305">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Canelas</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quintao</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scaff</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasconcelos</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brotto</surname>
                    <given-names>MW</given-names>
                  </name>
                </person-group>
                <year>1983</year>
                <article-title>Cerebrotendinous xanthomatosis: clinical and laboratory study of 2 cases.</article-title>
                <source>Acta Neurol Scand</source>
                <volume>67</volume>
                <fpage>305</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">6410671</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.cruysberg.2002.1975">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cruysberg</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Cerebrotendinous xanthomatosis: juvenile cataract and chronic diarrhea before the onset of neurologic disease.</article-title>
                <source>Arch Neurol</source>
                <volume>59</volume>
                <fpage>1975</fpage>
                <pub-id pub-id-type="pmid">12470193</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.cruysberg.1991.606">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cruysberg</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wevers</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolboom</surname>
                    <given-names>JJ</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Juvenile cataract associated with chronic diarrhea in pediatric cerebrotendinous xanthomatosis.</article-title>
                <source>Am J Ophthalmol</source>
                <volume>112</volume>
                <fpage>606</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">1951610</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.cruysberg.1995.597">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cruysberg</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wevers</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Engelen</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinckers</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Spreeken</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolboom</surname>
                    <given-names>JJ</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Ocular and systemic manifestations of cerebrotendinous xanthomatosis.</article-title>
                <source>Am J Ophthalmol</source>
                <volume>120</volume>
                <fpage>597</fpage>
                <lpage>604</lpage>
                <pub-id pub-id-type="pmid">7485361</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.de_stefano.2001.121">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Stefano</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortilla</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis.</article-title>
                <source>Brain</source>
                <volume>124</volume>
                <fpage>121</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">11133792</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.dotti.2000.1017">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garuti</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calandra</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Cerebrotendinous xanthomatosis with predominant parkinsonian syndrome: further confirmation of the clinical heterogeneity.</article-title>
                <source>Mov Disord</source>
                <volume>15</volume>
                <fpage>1017</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11009219</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.dotti.1994.1721">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Signorini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caputo</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venturi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filosomi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guazzi</surname>
                    <given-names>GC</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>Cerebrotendinous xanthomatosis (van Bogaert-Scherer-Epstein disease): CT and MR findings.</article-title>
                <source>AJNR Am J Neuroradiol</source>
                <volume>15</volume>
                <fpage>1721</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">7847220</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.dotti.1996.12">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garuti</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calandra</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Clinical and genetic variability of CTX</article-title>
                <comment>(Abstract)</comment>
                <source>Eur J Neurol</source>
                <volume>3</volume>
                <supplement>Suppl 5</supplement>
                <fpage>12</fpage>
              </element-citation>
            </ref>
            <ref id="ctx.REF.dotti.2004.185">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lutjohann</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Bergmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Normalisation of serum cholestanol concentration in a patient with cerebrotendinous xanthomatosis by combined treatment with chenodeoxycholic acid, simvastatin and LDL apheresis.</article-title>
                <source>Neurol Sci</source>
                <volume>25</volume>
                <fpage>185</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">15549503</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.dotti.1995.106">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manneschi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Mitochondrial enzyme deficiency in cerebrotendinous xanthomatosis.</article-title>
                <source>J Neurol Sci</source>
                <volume>129</volume>
                <fpage>106</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">7608723</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.dotti.1998.723">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mondillo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plewnia</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Agricola</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Cerebrotendinous xanthomatosis: evidence of lipomatous hypertrophy of the atrial septum.</article-title>
                <source>J Neurol</source>
                <volume>245</volume>
                <fpage>723</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9808240</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.dotti.2001.696">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rufa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Cerebrotendinous xanthomatosis: heterogeneity of clinical phenotype with evidence of previously undescribed ophthalmological findings.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>24</volume>
                <fpage>696</fpage>
                <lpage>706</lpage>
                <pub-id pub-id-type="pmid">11804206</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.dotti.1991.371">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salen</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Cerebrotendinous xanthomatosis as a multisystem disease mimicking premature ageing.</article-title>
                <source>Dev Neurosci</source>
                <volume>13</volume>
                <fpage>371</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">1817044</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.farpour.1975.223">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Farpour</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahloudji</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1975</year>
                <article-title>Familial cerebrotendinous xanthomatosis. Report of a new family and review of the literature.</article-title>
                <source>Arch Neurol</source>
                <volume>32</volume>
                <fpage>223</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">1124985</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.federico.1994.2218">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>Treatment of cerebrotendinous xanthomatosis.</article-title>
                <source>Neurology</source>
                <volume>44</volume>
                <fpage>2218</fpage>
                <pub-id pub-id-type="pmid">7970001</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.federico.2001.1743">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Cerebrotendinous xanthomatosis.</article-title>
                <source>Neurology</source>
                <volume>57</volume>
                <fpage>1743</fpage>
                <pub-id pub-id-type="pmid">11706139</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.federico.2003.633">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Cerebrotendinous xanthomatosis: clinical manifestations, diagnostic criteria, pathogenesis, and therapy.</article-title>
                <source>J Child Neurol</source>
                <volume>18</volume>
                <fpage>633</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">14572142</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.federico.1993.67">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lore</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nuti</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Cerebrotendinous xanthomatosis: pathophysiological study on bone metabolism.</article-title>
                <source>J Neurol Sci</source>
                <volume>115</volume>
                <fpage>67</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">8468594</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.federico.1991.734">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Volpi</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Muscle mitochondrial changes in cerebrotendinous xanthomatosis.</article-title>
                <source>Ann Neurol</source>
                <volume>30</volume>
                <fpage>734</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">1763899</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.federico.1987.360">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmeri</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciacci</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malandrini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alessandrini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salen</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guazzi</surname>
                    <given-names>GC</given-names>
                  </name>
                </person-group>
                <year>1987</year>
                <article-title>Peripheral neuropathy in CTX: seven cases in two families.</article-title>
                <source>Neurology</source>
                <volume>37</volume>
                <supplement>Suppl 1</supplement>
                <fpage>360</fpage>
              </element-citation>
            </ref>
            <ref id="ctx.REF.federico.1989">
              <mixed-citation publication-type="book">Federico A. Xantomatosi cerebrotendinea. Aspetti clinici e biochimici. In: Andria G, Dagna Bricarelli F, Del Porto G, De Marchi M, Federico A, eds. <italic toggle="yes">Patologia Genetica ad Esordio Tardivo</italic>. Bologna, Italy: Monduzzi Ed. 1989:29-38.</mixed-citation>
            </ref>
            <ref id="ctx.REF.fiorelli.1990.76">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fiorelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Piero</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bastianello</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bozzao</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1990</year>
                <article-title>Cerebrotendinous xanthomatosis: clinical and MRI study (a case report).</article-title>
                <source>J Neurol Neurosurg Psychiatry</source>
                <volume>53</volume>
                <fpage>76</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">2303834</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.frihayed.2005.992">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Frih-Ayed</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boughammoura-Bouatay</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben Hamda</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chebel</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben Farhat</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Hypertrophy of the atrial septum in the cerebrotendinous xanthomatosis.</article-title>
                <source>Rev Med Interne</source>
                <volume>26</volume>
                <fpage>992</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">16236394</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.fujiyama.1991.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fujiyama</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuriyama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arima</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shibata</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagata</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takenaga</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osame</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Atherogenic risk factors in cerebrotendinous xanthomatosis.</article-title>
                <source>Clin Chim Acta</source>
                <volume>200</volume>
                <fpage>1</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">1934506</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.gallus.2006.143">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gallus</surname>
                    <given-names>GN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene.</article-title>
                <source>Neurol Sci</source>
                <volume>27</volume>
                <fpage>143</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16816916</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.gilad.1999.405">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gilad</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lampl</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lev</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadeh</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Cerebrotendinous xanthomatosis without xanthomas.</article-title>
                <source>Clin Genet</source>
                <volume>56</volume>
                <fpage>405</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">10668932</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.ginanneschi.2013.268">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ginanneschi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mignarri</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mondelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallus</surname>
                    <given-names>GN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Puppo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giorgi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Polyneuropathy in cerebrotendinous xanthomatosis and response to treatment with chenodeoxycholic acid.</article-title>
                <source>J Neurol</source>
                <volume>260</volume>
                <fpage>268</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">22878431</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.grandas.2002.1396">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Grandas</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin-Moro</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia-Munozguren</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anaya</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Early-onset parkinsonism in cerebrotendinous xanthomatosis.</article-title>
                <source>Mov Disord</source>
                <volume>17</volume>
                <fpage>1396</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12465096</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.guerrera.2010.1189">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guerrera</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stromillo</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mignarri</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Battaglini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marino</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Perri</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Stefano</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Clinical relevance of brain volume changes in patients with cerebrotendinous xanthomatosis.</article-title>
                <source>J Neurol Neurosurg Psychiatry</source>
                <volume>81</volume>
                <fpage>1189</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">20972203</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.hansson.2007.504">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hansson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Floren</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Bahr</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van't Hooft</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meaney</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eggertsen</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bj&#x000f6;rkhem</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Unique patient with cerebrotendinous xanthomatosis. Evidence for presence of a defect in a gene that is not identical to sterol 27-hydroxylase.</article-title>
                <source>J Intern Med</source>
                <volume>261</volume>
                <fpage>504</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">17444890</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.hatanaka.1990.390">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hatanaka</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yasuda</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hidaka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harada</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okabe</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumoto</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hukuda</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shigeta</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>1990</year>
                <article-title>Spinal cord compression with paraplegia in xanthomatosis due to normocholesterolemic sitosterolemia.</article-title>
                <source>Ann Neurol</source>
                <volume>28</volume>
                <fpage>390</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">2241122</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.idouji.1991.402">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Idouji</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuriyama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujiyama</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osame</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoshita</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Hypothyroidism with increased serum levels of cholestanol and bile alcohol &#x02014; analogous symptoms to cerebrotendinous xanthomatosis.</article-title>
                <source>Rinsho Shinkeigaku</source>
                <volume>31</volume>
                <fpage>402</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">1914325</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.inglese.2003.495">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Inglese</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeStefano</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pagani</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Comi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filippi</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Quantification of brain damage in cerebrotendinous xanthomatosis with magnetization transfer MR imaging.</article-title>
                <source>AJNR Am J Neuroradiol</source>
                <volume>24</volume>
                <fpage>495</fpage>
                <lpage>500</lpage>
                <pub-id pub-id-type="pmid">12637303</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.kerleau.1993.1460">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kerleau</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lefebvre</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houdent</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolf</surname>
                    <given-names>LM</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Early coronary atheroma. A little known complication of cerebrotendinous xanthomatosis.</article-title>
                <source>Presse Med</source>
                <volume>22</volume>
                <fpage>1460</fpage>
                <pub-id pub-id-type="pmid">8265531</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.khan.2013.956">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>AO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aldahmesh</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohamed</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alkuraya</surname>
                    <given-names>FS</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Juvenile cataract morphology in 3 siblings not yet diagnosed with cerebrotendinous xanthomatosis.</article-title>
                <source>Ophthalmology</source>
                <volume>120</volume>
                <fpage>956</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">23375591</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.ko.2001.30">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ko</surname>
                    <given-names>KF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>KW</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Cerebrotendinous xanthomatosis in three siblings from a Chinese family.</article-title>
                <source>Singapore Med J</source>
                <volume>42</volume>
                <fpage>30</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">11361235</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.kuriyama.1991.225">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kuriyama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujiyama</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshidome</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takenaga</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumuro</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kasama</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukuda</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuramoto</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoshita</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seyama</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okatu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osame</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Cerebrotendinous xanthomatosis: clinical and biochemical evaluation of eight patients and review of the literature.</article-title>
                <source>J Neurol Sci.</source>
                <volume>102</volume>
                <fpage>225</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">2072121</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.leitersdorf.1993.2488">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leitersdorf</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reshef</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meiner</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levitzki</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dann</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkman</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cali</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klapholz</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berginer</surname>
                    <given-names>VM</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews of Moroccan origin.</article-title>
                <source>J Clin Invest</source>
                <volume>91</volume>
                <fpage>2488</fpage>
                <lpage>96</lpage>
                <pub-id pub-id-type="pmid">8514861</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.leitersdorf.1994.907">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leitersdorf</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Safadi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meiner</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reshef</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bjorkhem</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedlander</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morkos</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berginer</surname>
                    <given-names>VM</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>Cerebrotendinous xanthomatosis in the Israeli Druze: molecular genetics and phenotypic characteristics.</article-title>
                <source>Am J Hum Genet</source>
                <volume>55</volume>
                <fpage>907</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">7977352</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.lorincz.2005.1459">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lorincz</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rainier</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fink</surname>
                    <given-names>JK</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Cerebrotendinous xanthomatosis: possible higher prevalence than previously recognized.</article-title>
                <source>Arch Neurol</source>
                <volume>62</volume>
                <fpage>1459</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">16157755</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.luyckx.2014.9">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Luyckx</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eyskens</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simons</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beckx</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van West</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dhar</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Long-term follow-up on the effect of combined therapy of bile acids and statins in the treatment of cerebrotendinous xanthomatosis: a case report.</article-title>
                <source>Clin Neurol Neurosurg</source>
                <volume>118</volume>
                <fpage>9</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">24529221</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.martini.2013.282">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Martini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mignarri</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruvio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valenti</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franci</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Puppo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nuti</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Long-term bone density evaluation in cerebrotendinous xanthomatosis: evidence of improvement after chenodeoxycholic acid treatment.</article-title>
                <source>Calcif Tissue Int</source>
                <volume>92</volume>
                <fpage>282</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">23212544</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.matsumuro.1990.207">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matsumuro</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumoto</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okatsu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuriyama</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1990</year>
                <comment>[A case of cerebrotendinous xanthomatosis with convulsive seizures]</comment>
                <source>Rinsho Shinkeigaku</source>
                <volume>30</volume>
                <fpage>207</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">2190743</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.mignarri.2012a.649">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mignarri</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Puppo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallus</surname>
                    <given-names>GN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giorgio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cerase</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monti</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2012a</year>
                <article-title>Cerebrotendinous xanthomatosis with progressive cerebellar vacuolation : six-year MRI follow-up.</article-title>
                <source>Neuroradiology</source>
                <volume>54</volume>
                <fpage>649</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">22415344</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.mignarri.2012b.99">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mignarri</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falcini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vella</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giorgio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallus</surname>
                    <given-names>GN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Puppo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vattimo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <year>2012b</year>
                <article-title>Parkinsonism as neurological presentation of late-onset cerebrotendinous xanthomatosis.</article-title>
                <source>Parkinsonism Relat Disord</source>
                <volume>18</volume>
                <fpage>99</fpage>
                <lpage>101</lpage>
                <pub-id pub-id-type="pmid">21764626</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.mignarri.2014.421">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mignarri</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallus</surname>
                    <given-names>GN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>A suspicion index for early diagnosis and treatment of cerebrotendinous xanthomatosis.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2014</year>
                <volume>37</volume>
                <fpage>421</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">24442603</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.mignarri.2011.783">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mignarri</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ballerini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallus</surname>
                    <given-names>GN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Puppo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galluzzi</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Clinical relevance and neurophysiological correlates of spasticity in cerebrotendinous xanthomatosis.</article-title>
                <source>J Neurol.</source>
                <volume>258</volume>
                <fpage>783</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">21104094</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.mimura.1993.227">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mimura</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuriyama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tokimura</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujiyama</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osame</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takesako</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Treatment of cerebrotendinous xanthomatosis with low-density lipoprotein (LDL)-apheresis.</article-title>
                <source>J Neurol Sci</source>
                <volume>114</volume>
                <fpage>227</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">8445406</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.moghadasian.2004.42">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moghadasian</surname>
                    <given-names>MH</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Cerebrotendinous xanthomatosis: clinical course, genotypes and metabolic backgrounds.</article-title>
                <source>Clin Invest Med</source>
                <volume>27</volume>
                <fpage>42</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">15061585</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.mondelli.1992.469">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mondelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scarpini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>Evoked potentials in cerebrotendinous xanthomatosis and effect induced by chenodeoxycholic acid.</article-title>
                <source>Arch Neurol</source>
                <volume>49</volume>
                <fpage>469</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">1316120</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.mondelli.2001.29">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mondelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sicurelli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scarpini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Cerebrotendinous xanthomatosis: 11-year treatment with chenodeoxycholic acid in five patients. An electrophysiological study.</article-title>
                <source>J Neurol Sci</source>
                <volume>190</volume>
                <fpage>29</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">11574103</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.morgan.1989.1011">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Morgan</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKenna</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bosanquet</surname>
                    <given-names>RC</given-names>
                  </name>
                </person-group>
                <year>1989</year>
                <article-title>Case of cerebrotendinous xanthomatosis. I: Unusual ophthalmic features.</article-title>
                <source>Br J Ophthalmol</source>
                <volume>73</volume>
                <fpage>1011</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">2611184</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.nagai.1996.571">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nagai</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mori</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takakura</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamai</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueno</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Japanese triplets with cerebrotendinous xanthomatosis are homozygous for a mutant gene coding for the sterol 27-hydroxylase (Arg441Trp).</article-title>
                <source>Neurology</source>
                <volume>46</volume>
                <fpage>571</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">8614539</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.ohnishi.1979.43">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ohnishi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamashita</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goto</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuroiwa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murakami</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikeda</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1979</year>
                <article-title>De- and remyelination and onion bulb in cerebrotendinous xanthomatosis.</article-title>
                <source>Acta Neuropathol (Berl)</source>
                <volume>45</volume>
                <fpage>43</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">760364</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.ohno.2001.95">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakurai</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanazawa</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Diphenylpyraline-responsive parkinsonism in cerebrotendinous xanthomatosis: long-term follow up of three patients.</article-title>
                <source>J Neurol Sci</source>
                <volume>182</volume>
                <fpage>95</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11137513</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.pastershank.1974.282">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pastershank</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yip</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sodhi</surname>
                    <given-names>HS</given-names>
                  </name>
                </person-group>
                <year>1974</year>
                <article-title>Cerebrotendinous xanthomatosis.</article-title>
                <source>J Can Assoc Radiol</source>
                <volume>25</volume>
                <fpage>282</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">4443363</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.peynet.1991.434">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Peynet</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laurent</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Liege</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lecoz</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gambert</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Legrand</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mikol</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warnet</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Cerebrotendinous xanthomatosis: treatments with simvastatin, lovastatin, and chenodeoxycholic acid in 3 siblings.</article-title>
                <source>Neurology</source>
                <volume>41</volume>
                <fpage>434</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">2006015</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.philippart.1969.603">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Philippart</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Bogaert</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>1969</year>
                <article-title>Cholestanolosis (cerebrotendinous xanthomatosis). A follow-up study on the original family.</article-title>
                <source>Arch Neurol</source>
                <volume>21</volume>
                <fpage>603</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">5355255</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.pierre.2008.s241">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pierre</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Setchell</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blyth</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Preece</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chakrapani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKiernan</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Prospective treatment of cerebrotendinous xanthomatosis with cholic acid therapy.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>31</volume>
                <supplement>Suppl 2</supplement>
                <fpage>S241</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">19125350</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.pilodelafuente.2011.1203">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pilo-de-la-Fuente</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jimenez-Escrig</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lorenzo</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pardo</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arias</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ares-Luque</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duarte</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mu&#x000f1;iz-P&#x000e9;rez</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobrido</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Cerebrotendinous xanthomatosis in Spain: clinical, prognostic, and genetic survey.</article-title>
                <source>Eur J Neurol</source>
                <volume>10</volume>
                <fpage>1203</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">21645175</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.rogelet.1992.541">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rogelet</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerard</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michotte</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masingue</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Destee</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>Cerebrotendinous xanthomatosis. 2 cases with magnetic resonance imaging.</article-title>
                <source>Rev Neurol (Paris)</source>
                <volume>148</volume>
                <fpage>541</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">1494725</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.rystedt.2002.259">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rystedt</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seyama</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buchmann</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berstad</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eggertsen</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bjorkhem</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Cerebrotendinous xanthomatosis: molecular characterization of two Scandinavian sisters.</article-title>
                <source>J Intern Med</source>
                <volume>252</volume>
                <fpage>259</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">12270007</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.salen.1978.82">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Salen</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zaki</surname>
                    <given-names>FG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sabesin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boehme</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shefer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mosbach</surname>
                    <given-names>EH</given-names>
                  </name>
                </person-group>
                <year>1978</year>
                <article-title>Intrahepatic pigment and crystal forms in patients with cerebrotendinous xanthomatosis (CTX).</article-title>
                <source>Gastroenterology</source>
                <volume>74</volume>
                <fpage>82</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">618433</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.schimschock.1968.688">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schimschock</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alvord</surname>
                    <given-names>EC</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Swanson</surname>
                    <given-names>PD</given-names>
                  </name>
                </person-group>
                <year>1968</year>
                <article-title>Cerebrotendinous xanthomatosis. Clinical and pathological studies.</article-title>
                <source>Arch Neurol</source>
                <volume>18</volume>
                <fpage>688</fpage>
                <lpage>98</lpage>
                <pub-id pub-id-type="pmid">5652996</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.schreiner.1975.405">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schreiner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopen</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skrede</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1975</year>
                <article-title>Cerebrotendinous xanthomatosis (cholestanolosis). Investigations on two sisters and their family.</article-title>
                <source>Acta Neurol Scand</source>
                <volume>51</volume>
                <fpage>405</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">1130172</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.sugama.2001.379">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sugama</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimura</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kubota</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seyama</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taira</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eto</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Frontal lobe dementia with abnormal cholesterol metabolism and heterozygous mutation in sterol 27-hydroxylase gene (CYP27).</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>24</volume>
                <fpage>379</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">11486904</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.tint.1989.633">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tint</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ginsberg</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salen</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shefer</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1989</year>
                <article-title>Chenodeoxycholic acid normalizes elevated lipoprotein secretion and catabolism in cerebrotendinous xanthomatosis.</article-title>
                <source>J Lipid Res</source>
                <volume>30</volume>
                <fpage>633</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">2760539</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.valdivielso.2004.680">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Valdivielso</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calandra</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duran</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garuti</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herrera</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonzalez</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Coronary heart disease in a patient with cerebrotendinous xanthomatosis.</article-title>
                <source>J Intern Med</source>
                <volume>255</volume>
                <fpage>680</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">15147532</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.van_bogaert.1962.433">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Van Bogaert</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>1962</year>
                <article-title>The framework of the xanthomatoses and their different types. 2. Secondary xanthomatoses.</article-title>
                <source>Rev Med Liege</source>
                <volume>17</volume>
                <fpage>433</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">13924474</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.van_bogaert.1937">
              <mixed-citation publication-type="book">Van Bogaert L, Scherer HJ, Epstein E. <italic toggle="yes">Une Forme Cerebrale de la Cholesterinose Generalisee</italic>. Paris, France: Masson et Cie; 1937.</mixed-citation>
            </ref>
            <ref id="ctx.REF.verrips.2000a.908">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Verrips</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoefsloot</surname>
                    <given-names>LH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steenbergen</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Theelen</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wevers</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gabreels</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Engelen</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Heuvel</surname>
                    <given-names>LP</given-names>
                  </name>
                </person-group>
                <year>2000a</year>
                <article-title>Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis.</article-title>
                <source>Brain</source>
                <volume>123</volume>
                <fpage>908</fpage>
                <lpage>19</lpage>
                <pub-id pub-id-type="pmid">10775536</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.verrips.1999a.1589">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Verrips</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nijeholt</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barkhof</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Engelen</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wesseling</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luyten</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wevers</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stam</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wokke</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Heuvel</surname>
                    <given-names>LP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keyser</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gabreels</surname>
                    <given-names>FJ</given-names>
                  </name>
                </person-group>
                <year>1999a</year>
                <article-title>Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis.</article-title>
                <source>Brain</source>
                <volume>122</volume>
                <fpage>1589</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">10430841</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.verrips.2000b.407">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Verrips</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Engelen</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>ter Laak</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gabreels-Festen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janssen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zwarts</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wevers</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gabreels</surname>
                    <given-names>FJ</given-names>
                  </name>
                </person-group>
                <year>2000b</year>
                <article-title>Cerebrotendinous xanthomatosis. Controversies about nerve and muscle: observations in ten patients.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>10</volume>
                <fpage>407</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">10899446</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.verrips.2000c.520">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Verrips</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Engelen</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wevers</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Geel</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cruysberg</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Heuvel</surname>
                    <given-names>LP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keyser</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gabreels</surname>
                    <given-names>FJ</given-names>
                  </name>
                </person-group>
                <year>2000c</year>
                <article-title>Presence of diarrhea and absence of tendon xanthomas in patients with cerebrotendinous xanthomatosis.</article-title>
                <source>Arch Neurol</source>
                <volume>57</volume>
                <fpage>520</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">10768627</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.verrips.1999b.233">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Verrips</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wevers</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Engelen</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keyser</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolthers</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barkhof</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stalenhoef</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Graaf</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janssen-Zijlstra</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Spreeken</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gabreels</surname>
                    <given-names>FJ</given-names>
                  </name>
                </person-group>
                <year>1999b</year>
                <article-title>Effect of simvastatin in addition to chenodeoxycholic acid in patients with cerebrotendinous xanthomatosis.</article-title>
                <source>Metabolism</source>
                <volume>48</volume>
                <fpage>233</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10024088</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.waterreus.1987.169">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Waterreus</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koopman</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolthers</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oosterhuis</surname>
                    <given-names>HJ</given-names>
                  </name>
                </person-group>
                <year>1987</year>
                <article-title>Cerebrotendinous xanthomatosis (CTX): a clinical survey of the patient population in The Netherlands.</article-title>
                <source>Clin Neurol Neurosurg</source>
                <volume>89</volume>
                <fpage>169</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">3665290</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.yahalom.2013.78">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yahalom</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsabari</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molshatzki</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ephraty</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hassin-Baer</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Neurological outcome in cerebrotendinous xanthomatosis treated with chenodeoxycholic acid: early versus late diagnosis.</article-title>
                <source>Clin Neuropharmacol</source>
                <volume>36</volume>
                <fpage>78</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">23673909</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="ctx.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="ctx.Suggested_Reading.reflist0">
            <ref id="ctx.REF.bj_rkhem.2010.46">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bj&#x000f6;rkhem</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hansson</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challenge.</article-title>
                <source>Biochem Biophys Res Commun</source>
                <volume>396</volume>
                <fpage>46</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">20494109</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.keren.2009.6">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Keren</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falik-Zaccai</surname>
                    <given-names>TC</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Cerebrotendinous xanthomatosis (CTX): a treatable lipid storage disease.</article-title>
                <source>Pediatr Endocrinol Rev</source>
                <volume>7</volume>
                <fpage>6</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">19696711</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.sedel.2008.295">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sedel</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tourbah</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fontaine</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lubetzki</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumann</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saudubray</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyon-Caen</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Leukoencephalopathies associated with inborn errors of metabolism in adults.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>31</volume>
                <fpage>295</fpage>
                <lpage>307</lpage>
                <pub-id pub-id-type="pmid">18344012</pub-id>
              </element-citation>
            </ref>
            <ref id="ctx.REF.sundaram.2008.456">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sundaram</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bove</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lovell</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sokol</surname>
                    <given-names>RJ</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Mechanisms of disease: Inborn errors of bile acid synthesis.</article-title>
                <source>Nat Clin Pract Gastroenterol Hepatol</source>
                <volume>5</volume>
                <fpage>456</fpage>
                <lpage>68</lpage>
                <pub-id pub-id-type="pmid">18577977</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="ctx.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="ctx.Author_Notes">
          <title>Author Notes</title>
          <p>Antonio Federico is a full professor of Clinical Neurology and Director of the Department of Neurological and Behavioral Sciences, University of Siena. Maria Teresa Dotti is an associate professor at the University of Siena. Gian Nicola Gallus is a PhD student in the PhD Program of Applied Neurological Sciences, Department of Neurological and Behavioral Sciences, University of Siena.</p>
        </sec>
        <sec id="ctx.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>14 April 2016 (ma) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>1 August 2013 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>20 October 2011 (cd) Revision: deletion/duplication analysis available clinically</p>
            </list-item>
            <list-item>
              <p>16 November 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>25 January 2008 (cd) Revision: prenatal testing available</p>
            </list-item>
            <list-item>
              <p>7 February 2006 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>16 July 2003 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>18 December 2002 (af) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="ctx.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Different localization and severity of tendon xanthomas in CTX. Besides the classic xanthomas of the Achilles tendon (A), xanthomas of the patellar tendon (B), the extensor tendons of the hand (C), and the extensor tendons of the elbow (D) have been observed.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ctx-Image001" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="ctx.F2" orientation="portrait">
          <label>Figure 2. </label>
          <caption>
            <p>MRI findings in three persons with CTXA. Signal alterations of cerebral peduncleB. Signal abnormalities of corona radiata and subcortical white matterC. Hyperintensities of dentate nuclei and cerebellar white matter</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ctx-Image002" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="ctx.F3" orientation="portrait">
          <label>Figure 3. </label>
          <caption>
            <p>Clinical features of 55 individuals with CTX (27 males, 28 females) [<xref ref-type="bibr" rid="ctx.REF.mignarri.2014.421">Mignarri et al 2014</xref>]; <bold>*</bold> refers to features that were assessed in only a subset of the 55 individuals (i.e., osteoporosis was seen in 20/30 affected individuals).</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ctx-Image003" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
